Edition:
India

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

4.21USD
26 Jun 2019
Change (% chg)

$-0.29 (-6.44%)
Prev Close
$4.50
Open
$4.50
Day's High
$4.50
Day's Low
$4.21
Volume
295
Avg. Vol
2,650
52-wk High
$8.61
52-wk Low
$3.66

Latest Key Developments (Source: Significant Developments)

Alpine Immune Sciences- On May 20, Kite Pharma Provided Co Notice Of Termination Of License, Research Agreement, By And Between Ais Operating Co Inc
Friday, 24 May 2019 

May 24 (Reuters) - Alpine Immune Sciences Inc ::ALPINE IMMUNE SCIENCES- ON MAY 20, KITE PHARMA PROVIDED CO NOTICE OF TERMINATION OF LICENSE, RESEARCH AGREEMENT, BY AND BETWEEN AIS OPERATING CO INC.ALPINE IMMUNE SCIENCES INC - KITE TERMINATED AGREEMENT FOLLOWING EXPIRATION OF RESEARCH TERM.ALPINE IMMUNE-UPON TERMINATION, CONFIDENTIALITY,INDEMNITY OBLIGATIONS OF PARTIES WILL SURVIVE, LICENSES GRANTED TO KITE UNDER AGREEMENT WILL TERMINATE.ALPINE IMMUNE SCIENCES - PURSUANT TO TERMS OF AGREEMENT, TERMINATION WILL BE EFFECTIVE ON JUNE 20, 2019, 30 DAYS AFTER EFFECTIVENESS OF KITE'S NOTICE.  Full Article

Alpine Immune Sciences Provides Corporate Update And Reports Full Year 2017 Financial Results
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Alpine Immune Sciences Inc ::ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2017 FINANCIAL RESULTS.ALPINE IMMUNE SCIENCES - EXPECTS TO HAVE CASH TO FUND OPERATIONS INTO 2020, INCLUDING CLINICAL ADVANCEMENT OF ITS LEAD PROGRAMS ALPN-101 AND ALPN-202.  Full Article

Alpine Immune Sciences qtrly earnings per share ‍$0.18​
Tuesday, 14 Nov 2017 

Nov 13 (Reuters) - Alpine Immune Sciences Inc ::Alpine Immune Sciences reports corporate update and third quarter 2017 financial results.Q3 revenue $100,000 versus $700,000.Alpine Immune Sciences Inc - ‍company expects to have cash to fund operations into 2020​.Alpine Immune Sciences Inc qtrly earnings per share ‍$0.18​.  Full Article